Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 132

1.

Chemotherapy Improved Pulmonary Arterial Hypertension in a Patient with Chronic-Active Epstein-Barr Virus Infection.

Akagi S, Miki T, Sando Y, Fujii N, Sarashina T, Nakamura K, Ito H.

Int Heart J. 2020 Jan 31;61(1):191-194. doi: 10.1536/ihj.19-419. Epub 2020 Jan 17.

2.

Bilateral lung transplantation after caesarean section in pregnancy with severe pulmonary arterial hypertension: A case report.

Ye J, Chen JY, Xu N, Wu B, Wang ZP, Xu HY, Ma JQ.

Medicine (Baltimore). 2019 Nov;98(47):e18109. doi: 10.1097/MD.0000000000018109.

3.

Novel EIF2AK4 mutations in histologically proven pulmonary capillary hemangiomatosis and hereditary pulmonary arterial hypertension.

Abou Hassan OK, Haidar W, Arabi M, Skouri H, Bitar F, Nemer G, Akl IB.

BMC Med Genet. 2019 Nov 11;20(1):176. doi: 10.1186/s12881-019-0915-7.

4.

Macrophage activation syndrome and pulmonary arterial hypertension in a patient with adult-onset Still disease: A case report.

Zeng F, Deng G, Luo H, Zuo X, Xie Y.

Medicine (Baltimore). 2019 Nov;98(44):e17427. doi: 10.1097/MD.0000000000017427.

6.

Intrauterine Growth Restriction Programs Intergenerational Transmission of Pulmonary Arterial Hypertension and Endothelial Dysfunction via Sperm Epigenetic Modifications.

Zhang Z, Luo X, Lv Y, Yan L, Xu S, Wang Y, Zhong Y, Hang C, Jyotsnav J, Lai D, Shen Z, Xu X, Ma X, Chen Z, Pan Y, Du L.

Hypertension. 2019 Nov;74(5):1160-1171. doi: 10.1161/HYPERTENSIONAHA.119.13634. Epub 2019 Oct 9.

PMID:
31596625
7.

Correlation between right ventricular-pulmonary artery coupling and the prognosis of patients with pulmonary arterial hypertension.

Nie L, Li J, Zhang S, Dong Y, Xu M, Yan M, Zhang G, Song L.

Medicine (Baltimore). 2019 Oct;98(40):e17369. doi: 10.1097/MD.0000000000017369.

8.

Assessment of Prognostic Factors and Natural History of Idiopathic Pulmonary Arterial Hypertension in Eastern India.

Vinayak M, Sharma A, Sinha DP.

J Assoc Physicians India. 2019 Oct;67(10):57-61.

PMID:
31571454
9.

Echocardiographic variables with prognostic value in pulmonary arterial hypertension.

Dandel M.

Int J Cardiol. 2019 Nov 1;294:59. doi: 10.1016/j.ijcard.2019.07.009. No abstract available.

PMID:
31522721
10.
11.

Economic evaluation of sildenafil for the treatment of pulmonary arterial hypertension in Indonesia.

Lilyasari O, Subekti Y, Atika N, Dinarti LK, Putri S, Opitasari C, Anggraini AB, Bussabawalai T, Teerawattananon Y.

BMC Health Serv Res. 2019 Aug 14;19(1):573. doi: 10.1186/s12913-019-4422-5.

12.

Molecular genetic framework underlying pulmonary arterial hypertension.

Southgate L, Machado RD, Gräf S, Morrell NW.

Nat Rev Cardiol. 2020 Feb;17(2):85-95. doi: 10.1038/s41569-019-0242-x. Epub 2019 Aug 12. Review.

PMID:
31406341
13.

CD146-HIF-1α hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension.

Luo Y, Teng X, Zhang L, Chen J, Liu Z, Chen X, Zhao S, Yang S, Feng J, Yan X.

Nat Commun. 2019 Aug 7;10(1):3551. doi: 10.1038/s41467-019-11500-6. Erratum in: Nat Commun. 2019 Sep 5;10(1):4098.

14.

Transition from intravenous treprostinil to enteral selexipag in an infant with pulmonary arterial hypertension.

Koo R, Lo J, Bock MJ.

Cardiol Young. 2019 Jun;29(6):849-851. doi: 10.1017/S1047951119001082.

PMID:
31379316
15.

Characteristics and risk factors for pulmonary arterial hypertension associated with primary Sjögren's syndrome: 15 new cases from a single center.

Zhang N, Zhao Y, Wang H, Sun W, Chen M, Fan Q, Yang Z, Wei W.

Int J Rheum Dis. 2019 Sep;22(9):1775-1781. doi: 10.1111/1756-185X.13671. Epub 2019 Jul 31.

PMID:
31368254
16.

Decrease in Cerebral Oxygen Saturation During the 6-Minute Walk Test in Pediatric Pulmonary Arterial Hypertension.

Orgun LT, Öztürk Z, Canbeyli FH, Yapar D, Gücüyener K, Kula S.

Pediatr Cardiol. 2019 Oct;40(7):1494-1502. doi: 10.1007/s00246-019-02174-4. Epub 2019 Jul 31.

PMID:
31367954
17.

Is there a role for prostanoid-mediated inhibition of IL-6 trans-signalling in the management of pulmonary arterial hypertension?

Durham GA, Palmer TM.

Biochem Soc Trans. 2019 Aug 30;47(4):1143-1156. doi: 10.1042/BST20190046. Epub 2019 Jul 24. Review.

PMID:
31341036
18.

Nintedanib ameliorates experimental pulmonary arterial hypertension via inhibition of endothelial mesenchymal transition and smooth muscle cell proliferation.

Tsutsumi T, Nagaoka T, Yoshida T, Wang L, Kuriyama S, Suzuki Y, Nagata Y, Harada N, Kodama Y, Takahashi F, Morio Y, Takahashi K.

PLoS One. 2019 Jul 24;14(7):e0214697. doi: 10.1371/journal.pone.0214697. eCollection 2019.

19.

Checkpoint Kinase 1 Promotes the Development of Pulmonary Arterial Hypertension.

Satoh K, Kikuchi N, Kurosawa R, Shimokawa H.

Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1504-1506. doi: 10.1161/ATVBAHA.119.312969. Epub 2019 Jul 24. No abstract available.

PMID:
31339778
20.

HDL Cholesterol as a Marker of Disease Severity and Prognosis in Patients with Pulmonary Arterial Hypertension.

Jonas K, Kopeć G.

Int J Mol Sci. 2019 Jul 18;20(14). pii: E3514. doi: 10.3390/ijms20143514. Review.

Supplemental Content

Loading ...
Support Center